He is the Founder Director of Institute of Genomics and Integrative Biology (IGIB), New Delhi and the Chief Mentor of Open Source for Drug Discovery (OSDD)[3][4][5] Project.
[citation needed] He has also conceptualized the Ayurgenomics project that aims to integrate the principles of personalized medicine from Ayurveda, an ancient Indian medical system with modern genomics to bridge the gap from genotype to phenotype.
Brahmachari is the Chief Mentor of CSIR-Open Source Drug Discovery (OSDD) project, a CSIR-led Team India Consortium with global partnership.
Emerging as India’s first crowd sourcing initiative, OSDD is today a global translational research platform with more than 7500 participants from 130 countries.
[6][7] He was conferred the Banga Bibhushan Title, the highest state civilian award by the Government of West Bengal in recognition of his outstanding contributions to the field of Life Sciences in 2013.
[8] He has been selected as one of the Fierce's Top 10 Biotech Techies for his outstanding contribution to the field of genomics and open source drug discovery.
"[12] His claims regarding the first mapping of the Mycobaterium tuberculosis bacterial genome and the identification of a potential anti-tuberculosis drug candidate from the OSDD project invited severe criticism for being inaccurate and misguiding.
The Nature article had been corrected multiple times, in an unprecedented fashion due to factual inaccuracies in the reporting by the correspondent [13]